DIVIS LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE1097.90-3.15 (-0.29 %)
PREV CLOSE ( ) 1101.05
OPEN PRICE ( ) 1101.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1097.90 (269)
VOLUME 31206
TODAY'S LOW / HIGH ( )1082.15 1115.00
52 WK LOW / HIGH ( )605.75 1220
NSE1100.40-0.55 (-0.05 %)
PREV CLOSE( ) 1100.95
OPEN PRICE ( ) 1100.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1100.40 (529)
VOLUME 1278580
TODAY'S LOW / HIGH( ) 1082.15 1116.90
52 WK LOW / HIGH ( )611 1223
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Murali K Divi - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23(p)/divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 2378 6300

Email mail@divislaboratories.com

Website www.divislaboratories.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
28May Board recommends Dividend
Divis Laboratories Ltd has informed BSE that the Board of Directors of t..
17May Infosys, Divis Laboratories and Zensar
Infosys Finacle, part of EdgeVerve Systems, a wholly-owned subsidiary of..
17May USFDA inspects Divis Laboratories’ fac
Divis Laboratories’ Unit-I at Choutuppal in state of Telangana has been..
17May Divis Laboratories rises on successful
Divis Laboratories is currently trading at Rs. 1177.95, up by 11.80 poin..
16May Announcement Under Regulation 30 (LOD
Divi's Laboratories hereby announces that its Unit-I at Choutuppal, Tela..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit26168695.8
Gross Profit 3960.5 12193.6
Operating Profit 4346.713631.1
Net Sales 10879.538372.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 6682.00 (2.23%)
M.Cap (Rs. in Cr)14198.78
Astrazeneca Pharma I (BSE)
 1415.45 (8.28%)
M.Cap (Rs. in Cr)3538.63
Glaxosmithkline Phar (BSE)
 2800.75 (2.05%)
M.Cap (Rs. in Cr)23723.20
Merck (BSE)
 2433.20 (2.13%)
M.Cap (Rs. in Cr)4038.96
SMS Lifesciences (BSE)
 386.70 (14.44%)
M.Cap (Rs. in Cr)116.91
Shareholding Pattern
PROMOTERS 52.05%
MUTUAL FUNDS/UTI 15.45%
NON-INSTITUTION 13.77%
FI/BANKS/INSURANCE 0.32%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.